SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-081214
Filing Date
2023-07-14
Accepted
2023-07-14 16:12:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2321302d1_424b5.htm 424B5 336674
2 EX-FILING FEES tm2321302d1_ex-filingfees.htm EX-FILING FEES 1159
3 GRAPHIC tm2321302d1_424b5img001.jpg GRAPHIC 9964
4 GRAPHIC tm2321302d1_424b5img002.jpg GRAPHIC 4640
5 GRAPHIC tm228976d1_s3img001.jpg GRAPHIC 6544
  Complete submission text file 0001104659-23-081214.txt   368502
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-263700 | Film No.: 231089267
SIC: 2834 Pharmaceutical Preparations